ReviR Therapeutics Launches '1,000 Cases, 1,000 Diagnoses' Initiative Offering Free Genetic Testing for Charcot-Marie-Tooth Disease

CMT is a group of hereditary peripheral neuropathies that cause nerve degeneration. Patients experience gradual muscle atrophy in the legs and arms, leading to abnormal hand and foot function, limited balance, and difficulties with walking and running.

Understand the typical symptoms of CMT and perform a self-check.

The prevalence of the disease is approximately 1/2500. However, many people remain undiagnosed or frequently experience misdiagnosis.

This disease is highly clinically and genetically heterogeneous, with multiple subtypes. Genetic testing is the gold standard for diagnosis. Achieving a clear diagnosis and subtype classification is not only crucial for the patient but also has a significant impact on future generations.

Understanding the Necessity of Genetic Testing

Project SynergyPeking University Third Hospital, Xiangya Third Hospital of Central South University, First Affiliated Hospital of Sun Yat-sen University, China-Japan Friendship Hospital, Capital Institute of PediatricsJointly advance, gathering top expert resources to promote the comprehensive development of CMT research, diagnosis, and treatment.

The testing fee is covered by the project, and you can choose.Go to the designated hospital, complete the sampling under the guidance of a professional physician,You can also apply for a "home sampling kit"., complete the testing via mail. All samples and data are strictly encrypted and de-identified when used for scientific research, technological innovation, and clinical application purposes, fully protecting your personal rights.